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Abstract 
Background: Prostatic pathologies have always 
stayed the reason of concern in men above 50 years 
of age; the most dreaded of these is prostatic 
carcinoma. Progress in medical field has led to 
development of new investigative and treatment 
modalities in this domain. The current study is 
aimed at determining the frequency of prostatic 
adenocarcinoma in men with clinical suspicion of 
malignancy using transurethral resection of the 
prostate (TURP)/trans rectal prostate needle biopsy, 
using modified Gleason scoring system. 
Methods: A descriptive cross-sectional study of 
histopathological findings of 178 specimens was 
conducted for men undergoing TURP/trans rectal 
needle biopsy during a period of 3 years from 
January 2014 to January 2017 at Benazir Bhutto 
Hospital, Rawalpindi, Pakistan. 
Results: The histopathological findings of 
TURP/trans rectal prostatic needle biopsies of 
43(24.2%) specimens confirmed prostatic 
adenocarcinoma. Of the rest 133 (74.7%) were 
diagnosed as benign prostatic hyperplasia, and 2 
(1.1%) squamous metaplasia. Mean age of all 
patients was 65.8±9.02 years. The tagging of the 43 
cases of prostatic adenocarcinoma on the basis of 
Gleason score disclosed that 17 cases (39.5%) had 
Gleason grade pattern IV  followed by 13 cases of 
Gleason grade pattern III (30.2%) and 8 cases of 
Gleason grade pattern II (18.6%). 
Conclusion: Prostatic adenocarcinoma was noted 
in 24.2% of our patients with clinical suspicion of 
prostatic malignancy. Grade IV and II Gleason grade 
was noted in majority of these patients. 
Keywords: Prostatic adenocarcinoma, Gleason 
score/grade, TURP, trans rectal needle biopsy. 
Introduction 
Prostate cancer is the second most commonly 
diagnosed cancer in men worldwide1.  The American 
Cancer Society’s estimates for prostate cancer in the 
United States for 2017 are about 180,890 new cases of 
prostate cancer with about 26,120 deaths from prostate 
cancer. Prostate cancer alone accounts for one out of 5 
diagnosis.2 In Pakistan, there was unavailability of 
precise data on the incidence and prevalence of 
prostate cancer. However, tumour registries have been 
established in the recent past.  Prostate cancer was the 
seventh most common cancer in men living in Karachi 
division (7.3%). However, it was the fifth most 
common tumour (6.63%) in northern areas as seen in a 
hospital based study.3 In another study in Punjab, the 
incidence of prostate cancer in men is 3.8%.4 Trans 
rectal ultrasound guided prostate biopsy is presently 
the ‘gold standard’ for the diagnosis of prostate cancer. 
Over the last decade, several extended and saturation 
biopsy schemes have been used.5 Trans rectal 
ultrasound guidance of biopsies allows multiple 
prostate cores to be obtained safely, with reduced 
sampling error and increased accuracy in diagnosing 
prostate cancer in men with palpable prostate 
abnormailties.6 Trans rectal ultrasound (TRUS)-
guided, systematic needle biopsy is the most reliable 
method to detect cancer of prostate on the basis of 
clinical suspicion due to raised PSA and abnormal 
DRE.7 Numerous techniques have been devised and 
implemented for detection of prostate cancer with 
biopsy. In 1989, Hodge et al recommended systematic 
sextant biopsies which were taken in parasagittal 
plane halfway between the lateral border and midline 
of the prostate on the right and left sides from the 
base, mid gland and apex of prostate.6,8 Stamey et al. 
recommended shifting of the biopsy more laterally to 
adequately sample the anterior horn of the peripheral 
zone.9 In 2000, Presti et al determined that six 
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systematic biopsies of the peripheral zone were not 
sufficient; minimum 8 core biopsies including the 
apex, mid-lobar area, mid-gland area, lateral mid-
gland area and lateral base should be done.10 Extended 
10-12 core biopsies are now a part of contemporary 
pathology practice and ensure greater sensitivity for 
prostate cancer detection.11 In 1966 Donald Gleason 
presented a score as a prognostic predictor for prostate 
cancer according to which Gleason grade is the sum of 
primary and secondary architectural patterns seen in 
histopathology specimens.12 International Society of 
Urological Pathology (ISUP) arranged consensus 
conferences in 2005 in San Antonio, Texas (USA) and 
subsequently in 2014 in Chicago (USA) which led to 
the development of prognostic grade groups (I-V).13 
Due to increased patient influx in our hospital and lack 
of sufficient equipment, specimens obtained from 
TURP (Transurethral Resection of Prostate) are also 
used to study histopathological pattern of prostate 
lesions. This study aims to determine the frequency of 
prostate adenocarcinoma in TRUS-guided needle 
biopsies and TURP specimen along with grading them 
according to the modified Gleason grading system. 
Materials And Methods 
This was a descriptive cross-sectional study carried 
out at the department of Histopathology, Benazir 
Bhutto Hospital, Rawalpindi from January 2014 to 
January 2017 for all the consecutive cases of TRUS 
needle biopsies and TURP specimens. Standard tissue 
sections were made from the specimens and stained by 
Hematoxylin and Eosin. Lab request forms and 
histopathology reports were retrieved and reviewed.  
New grade groups were assigned to all the cases and 
arranged in parallel to the previously assigned 
Gleason scores. Data was entered in IBM SPSS, version 
23 and descriptive statistics were calculated. Cross-
tabulations were made for the variables of age-groups 
according to the Gleason grade seen in all cases of 
Prostatic adenocarcinoma. Numbers (percentages) 
were calculated for categorical data such as the 
frequency of adenocarcinoma observed in TRUS-
guided biopsies and TURP specimens. 
Results 
178 specimens were collected from trans rectal needle 
biopsies and prostatic chips obtained by TURP. 43 
cases out of 178 specimens (24.2%) of prostatic 
adenocarcinoma were detected. (Table I and II) 
The rest 133 cases (74.7%) were that of benign prostatic 
hyperplasia. 2 cases of squamous metaplasia were also 
observed. The mean age of all the patients was 
65.86±9.02 years; ranging from 47 to 90 (Range=43) 
with the median of 65 years and mode of 70 years. 
Majority of the patients (38.8%) were of the age group 
61-70 years. (Table III and IV)  
 
Figure I. Prostate Chips Obtained by 
Transurethral Resection of Prostate 
 
Figure II. Benign Prostatic Hyperplasia 
 
 
Figure III. Gleason grade V prostate cancer 
The tagging of the 43 cases of prostatic 
adenocarcinoma on the basis of Gleason score 
disclosed that 17 cases (39.5%) had Gleason grade 
pattern IV  followed by 13 cases of Gleason grade 
pattern III (30.2%) and 8 cases of Gleason grade 
pattern II (18.6%).5 cases (11.7%) of grade pattern V 
were also seen. No case of grade pattern I was seen. 
According to old Gleason score 17 cases had Gleason 
score 8 while 21 cases of Gleason score 7 were seen. 
Out of the 21 cases with Gleason score 7, 8 cases were 
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placed in Grade pattern II according to ISUP system 
2014 after microscopic evaluation and 13 were placed 
in grade pattern III. All the 5 cases of Gleason score 9 
were assigned Grade V. (Table V) 
 
 
Figure IV. Grade V Gleason Grade Prostate cancer 
Table I: Table showing old Gleason scoring system and 
New Grade Groups as per ISUP 2014 
Gleason Scoring System 
based on primary and 
secondary architectural 
patterns 
New Grade Groups 
(ISUP 2014) 
Gleason score 3+3=6 Gleason Grade I 
Gleason score 3+4=7 Gleason Grade II 
Gleason score 4+3=7 Gleason Grade III 
Gleason score 4+4=8 Gleason Grade IV 
Gleason score 9,10 Gleason Grade V 
  
 
Table II: Types of Prostatic Lesions seen in sample 
 
Prostatic Lesion Frequency Percentage 
Benign prostatic 
hyperplasia 
133 74.7 
Adenocarcinoma 43 24.2 
Squamous metaplasia 2 1.1 
Total 178 100.0 
 
Table III: Age wise distribution of patients undergoing 
trans rectal needle biopsy 
 
Age Frequency Percentage 
40 to 50 years 4 2.2 
51 to 60 years 59 33.1 
61 to 70 years 69 38.8 
above 70 years 46 25.8 
Total 178 100.0 
Table IV: Age groups of patients classified according 
to modified Gleason grading for prostatic 
adenocarcinoma 
 
 
Grade 
Total 
2.00 3.00 4.00 5.00 
Age groups of 
patients 
51 to 60 
years 
3 5 2 1 11 
61 to 70 
years 
3 6 9 1 19 
above 70 
years 
2 2 6 3 13 
Total 8 13 17 5 43 
 
Table V: Classification of different Gleason scores in 
Grade groups 
 SCORE 
GRADE 7.00 8.00 9.00 Total 
2.00 8 0 0 8 
3.00 13 1 0 13 
4.00 0 17 0 17 
5.00 0 0 5 5 
TOTAL 21 17 5 43 
 
Discussion 
Trans rectal ultrasound-guided needed biopsy is now 
a well-recognized technique with respect to its 
accuracy in prostate cancer diagnosis.14 In our study 
we focused on the detection of prostatic 
adenocarcinoma in the prostatic chips as well as 
biopsy specimen over a period of three years in order 
to prolong the duration of our study as well as to 
include the adequate number of patients in the 
sample.15  
The cancer detection rate in our study was 24.2% while 
in the recent studies conducted in Pakistan, the 
detection of prostate cancer was much higher.3,16,17 The 
difference between the detection rates can be due to 
sample size variation and availability and utility of 
TRUS in different clinical settings. Similar variation of 
our result was seen with international studies as well. 
These differences, in addition to study population and 
duration can also be attributed to the fact that all the 
patients in those studies had raised PSA with or 
without prostatism.18-22  
The mean age of our cases of prostate cancer were 
found in concordance to all the mentioned researches. 
Gleason score was first proposed in 1966.11 After the 
changes made in 2014 by ISUP modified grade pattern 
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for prostatic adenocarcinoma has gained immense 
acceptability among urologists and pathologists.13 
Gleason score continues to be a very important 
predictor of prognosis of prostate cancer as well as for 
clinical management.23 There is a lot of difference 
between the present Gleason grading system practice 
and the original one. On needle core biopsy, Gleason 
grade patterns I and II are not assigned any longer due 
to two main reasons; bad reproducibility and because 
poor correlation was seen with radical 
prostatectomy.24,25Many studies show that a tertiary 
pattern might also be seen which worsens the 
prognosis, but does not make it worse than the next 
higher score still.26-29 There have been numerous 
changes in studying the oncology of prostate as well as 
grading methods. The ultimate goal of these grading 
patterns is better prognosis and good clinical 
management. At present the modified grading pattern 
is a translation of the old Gleason scoring system e.g. 
4+3=7 is Grade Group III. But with the passage of time 
histopathologists will learn to classify grades of 
prostate cancer directly on the basis of histological 
pattern seen under the microscope e.g. in grade III 
distinctly infiltrative margins are seen.30 
There are some limitations in the present study. 
Firstly, the data was collected from a single centre. 
Some of the patients were excluded from the study 
because of missing data. Finally, lymph node 
dissections were not done, so the Gleason pattern 
could not be correlated with the degree of spread. PSA 
screening is not done routinely in the current setting so 
this also reduces the detection rate of prostate cancer. 
Large scale multicentre studies are needed to 
overcome these limitations along with PSA screening 
which would help greatly in the early detection of 
prostatic adenocarcinoma. 
Conclusion 
24.2% of our patients undergoing biopsy for prostatic 
carcinoma were diagnosed adenocarcinoma 
histopathologically. Grade IV and II Gleason grade 
was noted in majority of these patients. 
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